Zelira Therapeutics Ltd (ZLD) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.530x

Based on the latest financial reports, Zelira Therapeutics Ltd (ZLD) has a cash flow conversion efficiency ratio of 0.530x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-2.27 Million ≈ $-1.61 Million USD) by net assets (AU$-4.29 Million ≈ $-3.04 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Zelira Therapeutics Ltd - Cash Flow Conversion Efficiency Trend (2004–2025)

This chart illustrates how Zelira Therapeutics Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Zelira Therapeutics Ltd (ZLD) total liabilities for a breakdown of total debt and financial obligations.

Zelira Therapeutics Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zelira Therapeutics Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
CirChem AB ST:CIRCHE	0.045x
Hopening SA PA:MLHPE	N/A
Mountview Estates PLC LSE:MTVW	0.060x
G Capital Public Company Limited BK:GCAP	-0.018x
Lexus Granito (India) Limited NSE:LEXUS	0.322x
Austin Metals Ltd AU:AYT	-0.024x
Ecora Resources PLC LSE:ECOR	0.005x
Dimet (Siam) Public Company Limited BK:DIMET	-0.055x

Annual Cash Flow Conversion Efficiency for Zelira Therapeutics Ltd (2004–2025)

The table below shows the annual cash flow conversion efficiency of Zelira Therapeutics Ltd from 2004 to 2025. For the full company profile with market capitalisation and key ratios, see ZLD stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$-4.29 Million ≈ $-3.04 Million	AU$-4.91 Million ≈ $-3.47 Million	1.144x	+8.76%
2024-06-30	AU$-4.17 Million ≈ $-2.95 Million	AU$-4.39 Million ≈ $-3.11 Million	1.052x	+560.04%
2023-06-30	AU$31.71 Million ≈ $22.44 Million	AU$-7.25 Million ≈ $-5.13 Million	-0.229x	+13.46%
2022-06-30	AU$35.69 Million ≈ $25.25 Million	AU$-9.43 Million ≈ $-6.67 Million	-0.264x	-15.97%
2021-06-30	AU$37.83 Million ≈ $26.77 Million	AU$-8.62 Million ≈ $-6.10 Million	-0.228x	-13.45%
2020-06-30	AU$34.55 Million ≈ $24.44 Million	AU$-6.94 Million ≈ $-4.91 Million	-0.201x	+81.34%
2019-06-30	AU$3.11 Million ≈ $2.20 Million	AU$-3.34 Million ≈ $-2.37 Million	-1.076x	-154.74%
2018-06-30	AU$6.21 Million ≈ $4.40 Million	AU$-2.62 Million ≈ $-1.86 Million	-0.422x	-51.54%
2017-06-30	AU$7.90 Million ≈ $5.59 Million	AU$-2.20 Million ≈ $-1.56 Million	-0.279x	-117.04%
2016-06-30	AU$-202.91K ≈ $-143.57K	AU$-331.82K ≈ $-234.78K	1.635x	+299.81%
2015-06-30	AU$357.87K ≈ $253.22K	AU$-292.89K ≈ $-207.24K	-0.818x	-122.24%
2014-06-30	AU$750.16K ≈ $530.78K	AU$-276.25K ≈ $-195.47K	-0.368x	-47.42%
2013-06-30	AU$1.04 Million ≈ $736.13K	AU$-259.89K ≈ $-183.89K	-0.250x	+41.03%
2012-06-30	AU$1.35 Million ≈ $956.78K	AU$-572.82K ≈ $-405.31K	-0.424x	-374.87%
2011-06-30	AU$661.35K ≈ $467.95K	AU$101.92K ≈ $72.12K	0.154x	+108.53%
2010-06-30	AU$654.33K ≈ $462.98K	AU$-1.18 Million ≈ $-836.78K	-1.807x	-185.06%
2009-06-30	AU$2.48 Million ≈ $1.75 Million	AU$-1.57 Million ≈ $-1.11 Million	-0.634x	+63.41%
2008-06-30	AU$1.28 Million ≈ $902.96K	AU$-2.21 Million ≈ $-1.56 Million	-1.733x	-273.67%
2007-06-30	AU$-14.84 Million ≈ $-10.50 Million	AU$-14.81 Million ≈ $-10.48 Million	0.998x	+309.39%
2006-06-30	AU$14.88 Million ≈ $10.53 Million	AU$-7.09 Million ≈ $-5.02 Million	-0.476x	-83.61%
2005-06-30	AU$9.88 Million ≈ $6.99 Million	AU$-2.56 Million ≈ $-1.81 Million	-0.260x	+21.82%
2004-06-30	AU$8.29 Million ≈ $5.87 Million	AU$-2.75 Million ≈ $-1.95 Million	-0.332x	--

About Zelira Therapeutics Ltd

AU:ZLD Australia Biotechnology

Market Cap

$4.21 Million

AU$5.95 Million AUD

Market Cap Rank

#28657 Global

#1617 in Australia

Share Price

AU$0.50

Change (1 day)

+0.00%

52-Week Range

AU$0.31 - AU$0.91

All Time High

AU$26.25